Virtus LifeSci Biotech Products ETF Rating $63.29 -0.54 (-0.85%) As of 02/21/2025 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartHoldingsOwnershipRatings Virtus LifeSci Biotech Products ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.BBP Aggregate RatingModerate Buy 2.77Holdings in BBP have an aggregate rating of Moderate Buy based on 655 analyst ratings issued in the past year covering 49 companies (82.6% of the portfolio).BBP Aggregate Price Target$63.29High Prediction$63.29Average Prediction$63.29Low Prediction$63.29Holdings in BBP have an aggregate price target of $63.29 and a range of $63.29 to $63.29 covering 49 companies (82.6% of the portfolio).BBP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy16 Buy rating(s)Moderate Buy25 Moderate Buy rating(s)Hold8 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Virtus LifeSci Biotech Products ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 49 BBP Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings2.42%ITCIIntra-Cellular Therapies$128.60+0.0%3.8947 of 5 stars2.53$103.62 -19.4%15Earnings ReportAnalyst ForecastNews Coverage2.04%SAGESage Therapeutics$7.31+2.2%4.6153 of 5 stars2.00$9.65 32.0%201.94%TVTXTravere Therapeutics$21.98-6.8%2.955 of 5 stars2.93$27.77 26.3%14Earnings ReportAnalyst ForecastNews CoverageGap Down1.94%HRMYHarmony Biosciences$34.56-0.9%4.731 of 5 stars3.00$53.67 55.3%9Analyst ForecastAnalyst RevisionNews Coverage1.93%MIRMMirum Pharmaceuticals$52.50-1.2%2.6993 of 5 stars3.09$57.10 8.8%11News Coverage1.93%HALOHalozyme Therapeutics$57.75+0.5%4.4627 of 5 stars2.60$62.78 8.7%10Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.89%NBIXNeurocrine Biosciences$120.69+3.9%4.9803 of 5 stars2.83$166.90 38.3%23Analyst DowngradeBuyback AnnouncementAnalyst RevisionGap Up1.88%BPMCBlueprint Medicines$92.25-2.2%2.9956 of 5 stars2.65$123.83 34.2%20Earnings ReportAnalyst Upgrade1.88%BBIOBridgeBio Pharma$36.85+0.1%4.8248 of 5 stars2.92$51.67 40.2%13Earnings ReportAnalyst ForecastInsider TradeNews Coverage1.85%AXSMAxsome Therapeutics$137.75+6.7%4.5296 of 5 stars3.00$157.64 14.4%15Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.83%BCRXBioCryst Pharmaceuticals$9.21-1.9%3.924 of 5 stars2.83$15.50 68.3%61.81%ALNYAlnylam Pharmaceuticals$250.59-0.2%4.4472 of 5 stars2.72$299.48 19.5%25Analyst ForecastInsider Trade1.78%INSMInsmed$81.06-3.0%4.0378 of 5 stars3.00$91.00 12.3%15Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage1.76%ACADACADIA Pharmaceuticals$19.95-1.7%3.0693 of 5 stars2.53$24.00 20.3%17Upcoming EarningsShort Interest ↓1.74%TGTXTG Therapeutics$30.88-0.2%4.4841 of 5 stars2.83$40.67 31.7%6Positive News1.74%MDGLMadrigal Pharmaceuticals$336.23-4.2%3.2893 of 5 stars2.69$351.67 4.6%131.73%IBRXImmunityBio$3.42-6.0%2.0758 of 5 stars3.00$13.58 297.2%4News Coverage1.73%AMGNAmgen$303.01+1.7%4.4634 of 5 stars2.46$314.09 3.7%24Insider TradePositive News1.72%ARDXArdelyx$5.06-11.6%4.5015 of 5 stars3.00$9.93 96.4%9Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews CoverageHigh Trading Volume1.71%RYTMRhythm Pharmaceuticals$56.07-2.9%4.0942 of 5 stars2.91$68.09 21.4%11Analyst ForecastInsider TradeNews Coverage1.70%GILDGilead Sciences$109.95-0.1%4.7853 of 5 stars2.72$102.08 -7.2%29Analyst UpgradeInsider TradeOptions VolumeAnalyst RevisionPositive News1.68%INCYIncyte$72.05+0.9%4.5328 of 5 stars2.35$75.59 4.9%201.67%PTCTPTC Therapeutics$50.69+0.6%3.6081 of 5 stars2.47$58.85 16.1%15Analyst ForecastNews Coverage1.66%TARSTarsus Pharmaceuticals$47.84-1.8%1.1673 of 5 stars3.00$56.00 17.1%7Gap Up1.66%ZLABZai Lab$33.78+9.0%2.5526 of 5 stars3.33$55.00 62.8%3Upcoming EarningsAnalyst RevisionNews CoverageGap UpHigh Trading Volume1.65%VRTXVertex Pharmaceuticals$484.24+0.8%4.1184 of 5 stars2.65$505.61 4.4%26Analyst DowngradeInsider TradeAnalyst RevisionPositive News1.65%LGNDLigand Pharmaceuticals$120.56-1.2%4.1424 of 5 stars3.00$147.00 21.9%6Positive News1.62%LEGNLegend Biotech$39.70+2.0%2.5296 of 5 stars3.00$79.50 100.3%12News Coverage1.61%SWTXSpringWorks Therapeutics$58.29-2.7%1.2401 of 5 stars3.00$71.50 22.7%6Earnings ReportAnalyst ForecastInsider TradeAnalyst RevisionNews Coverage1.61%DVAXDynavax Technologies$13.334.2783 of 5 stars2.33$21.50 61.3%3Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap Up1.60%KNSAKiniksa Pharmaceuticals$20.02+1.7%2.7924 of 5 stars3.00$36.60 82.8%5Upcoming Earnings1.58%BNTXBioNTech$120.01+1.8%2.4325 of 5 stars2.88$142.72 18.9%17Positive NewsHigh Trading Volume1.57%IMCRImmunocore$29.92+0.2%1.4211 of 5 stars2.54$65.64 119.4%131.56%UTHRUnited Therapeutics$361.10-1.7%4.3677 of 5 stars2.67$388.25 7.5%12Insider TradePositive News1.55%REGNRegeneron Pharmaceuticals$700.33+0.6%4.7635 of 5 stars2.76$973.13 39.0%25Dividend Announcement1.55%RAREUltragenyx Pharmaceutical$42.59-4.2%4.6248 of 5 stars2.93$93.50 119.5%14Analyst Forecast1.55%DAWNDay One Biopharmaceuticals$12.43+1.6%2.1076 of 5 stars3.00$35.71 187.3%9Upcoming EarningsInsider TradeNews Coverage1.54%FOLDAmicus Therapeutics$9.19+1.3%4.187 of 5 stars2.78$16.75 82.3%9Analyst DowngradeNews Coverage1.54%BMRNBioMarin Pharmaceutical$68.25-0.7%4.9188 of 5 stars2.70$93.81 37.4%23Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.53%TBPHTheravance Biopharma$9.31-3.6%1.219 of 5 stars2.40$13.75 47.7%51.52%ASNDAscendis Pharma A/S$152.43-1.4%3.1752 of 5 stars2.93$197.36 29.5%14Analyst Forecast1.52%EXELExelixis$36.85+5.0%4.6318 of 5 stars2.55$37.24 1.0%20Analyst UpgradeInsider TradeGap Up1.48%KRYSKrystal Biotech$187.86+2.9%4.4894 of 5 stars3.00$210.00 11.8%8Earnings ReportAnalyst ForecastAnalyst RevisionNews Coverage1.47%APLSApellis Pharmaceuticals$27.52-2.9%4.2376 of 5 stars2.63$46.71 69.7%19Short Interest ↓1.46%ROIVRoivant Sciences$10.68-0.4%2.5697 of 5 stars3.00$18.08 69.3%7Insider Trade1.46%NVAXNovavax$7.99+0.9%3.9708 of 5 stars2.33$17.83 123.2%6Analyst RevisionNews CoverageHigh Trading Volume1.46%BIIBBiogen$140.64+2.6%4.7395 of 5 stars2.43$211.85 50.6%30Analyst Forecast1.44%ADMAADMA Biologics$15.84-1.5%3.5142 of 5 stars3.25$21.25 34.2%41.43%AGIOAgios Pharmaceuticals$35.22+4.3%4.3332 of 5 stars2.50$56.33 60.0%8Earnings ReportShort Interest ↓ This page (NYSEARCA:BBP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Virtus LifeSci Biotech Products ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Virtus LifeSci Biotech Products ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BBP Stock Alerts